Insulet (PODD) Earnings Analysis

Insulet (PODD) has no confirmed upcoming earnings date. Last quarter (2026-02-18) it beat with EPS 1.55 USD vs 1.47 USD est (+5.4%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 36.87.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PODD next report earnings?

No confirmed upcoming earnings date is currently scheduled for PODD. This page updates as the calendar is published.

PODD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-181.55 USD1.47 USD+5.4%Beat
2025-11-061.24 USD1.14 USD+8.8%Beat
2025-08-071.17 USD0.92 USD+27.2%Beat
2025-02-201.15 USD1 USD+15%Beat
2024-11-070.9 USD0.76 USD+18.4%Beat
2024-08-080.55 USD0.564 USD-2.5%Miss

Beat rate: 5/6 (83%) over reported quarters with consensus data.

PODD valuation and analyst view

Trailing P/E36.87
Trailing EPS4.327 USD
Price / book8.54
Dividend yield0.00%
Market cap11.02B
Analyst consensusBuy (35 buy / 12 hold / 3 sell)
Avg price target223.71 USD

Related research pages

Frequently asked questions

When is Insulet (PODD)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for PODD. This page updates as the calendar is published.

Did PODD beat earnings last quarter?

In its 2026-02-18 report, PODD posted EPS of 1.55 USD versus a 1.47 USD estimate — a beat of 5.4%.

What is PODD's earnings track record?

Over the last 6 reported quarters with consensus data, PODD beat estimates 5 times (83%).

What is PODD's current P/E ratio and EPS?

PODD trades at a trailing P/E of 36.87 on trailing EPS of 4.326579601634613 USD.

What do analysts rate PODD?

Analyst consensus is "Buy" across 50 ratings (0 strong buy, 35 buy, 12 hold, 3 sell, 0 strong sell). Average 12-month price target: 223.71 USD.